Physician profile
Neil Ninan
NPI 1689970790
$4,894.56
in general payments reported to CMS, 2019-2025
15 companies · $3,791 in 2025
The $3,791 reported for 2025 was more than what 86% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $254 · 2021: $84.94 · 2022: $110 · 2023: $384 · 2024: $271 · 2025: $3,791.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Travel and Lodging: $1,071 · Food and Beverage: $874.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Travel and Lodging | $1,070.95 |
| Food and Beverage | $874.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,463.03 | 2025 | |
| Genzyme Corporation | $464.04 | 2023-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $150.56 | 2021-2024 | Ofev |
| Glaxosmithkline, LLC. | $124.99 | 2019 | |
| Siemens Medical Solutions USA, INC. | $124.91 | 2025 | |
| La Jolla Pharmaceutical Company | $114.89 | 2019 | |
| On Target Laboratories, INC | $90.00 | 2025 | Cytalux |
| Steris Corporation | $89.04 | 2025 | |
| Ethicon INC. | $69.25 | 2021 | |
| Mylan Specialty L.P. | $61.50 | 2022-2024 | Yupelri |
| Electromed, INC. | $50.27 | 2022 | |
| Genentech USA, INC. | $37.54 | 2019-2022 | |
| Pulmonx Corporation | $23.75 | 2025 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Inspire Medical Systems, INC. | $15.62 | 2023 | Inspire |
| Olympus America INC. | $15.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Ninan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.